AU714225B2 - Agents for inhibiting accumulation of visceral fat - Google Patents

Agents for inhibiting accumulation of visceral fat Download PDF

Info

Publication number
AU714225B2
AU714225B2 AU10117/97A AU1011797A AU714225B2 AU 714225 B2 AU714225 B2 AU 714225B2 AU 10117/97 A AU10117/97 A AU 10117/97A AU 1011797 A AU1011797 A AU 1011797A AU 714225 B2 AU714225 B2 AU 714225B2
Authority
AU
Australia
Prior art keywords
ala
amylase
solution
val
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU10117/97A
Other languages
English (en)
Other versions
AU1011797A (en
Inventor
Toshinao Goda
Toshiyuki Miyazaki
Toshihisa Morimoto
Ryuji Murayama
Sachiko Takase
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nagata Sangyo Co Ltd
Nisshin Pharma Inc
Original Assignee
Nagata Sangyo Co Ltd
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nagata Sangyo Co Ltd, Nisshin Seifun Group Inc filed Critical Nagata Sangyo Co Ltd
Publication of AU1011797A publication Critical patent/AU1011797A/en
Application granted granted Critical
Publication of AU714225B2 publication Critical patent/AU714225B2/en
Assigned to NAGATA SANGYO CO., LTD, NISSHIN PHARMA INC. reassignment NAGATA SANGYO CO., LTD Alteration of Name(s) in Register under S187 Assignors: NAGATA SANGYO CO., LTD, NISSHIN FLOUR MILLING CO. LTD.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/56—Protease inhibitors from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
AU10117/97A 1996-01-18 1997-01-10 Agents for inhibiting accumulation of visceral fat Ceased AU714225B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP08/23445 1996-01-18
JP02344596A JP3999825B2 (ja) 1996-01-18 1996-01-18 内臓脂肪蓄積抑制剤

Publications (2)

Publication Number Publication Date
AU1011797A AU1011797A (en) 1997-07-24
AU714225B2 true AU714225B2 (en) 1999-12-23

Family

ID=12110710

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10117/97A Ceased AU714225B2 (en) 1996-01-18 1997-01-10 Agents for inhibiting accumulation of visceral fat

Country Status (6)

Country Link
US (1) US5789380A (ja)
EP (1) EP0784978B1 (ja)
JP (1) JP3999825B2 (ja)
AU (1) AU714225B2 (ja)
CA (1) CA2195053C (ja)
DE (1) DE69720303T2 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09194392A (ja) * 1996-01-18 1997-07-29 Nisshin Flour Milling Co Ltd アミラーゼ阻害物質
TWI329516B (en) 2000-12-12 2010-09-01 Kaneka Corp Composition for preventing or ameliorating multiple risk factor syndromes and visceral fat-type obesity
JP4902140B2 (ja) * 2005-05-30 2012-03-21 長田産業株式会社 α−アミラーゼ阻害活性を有する蛋白質
WO2006135084A1 (ja) * 2005-06-14 2006-12-21 Kurume University 脂肪性肝炎または脂肪肝の予防または治療薬
WO2006135083A1 (ja) * 2005-06-14 2006-12-21 Kurume University 内臓脂肪症候群の予防または治療薬
EP2563394B1 (en) * 2010-04-30 2018-03-21 Beth Israel Deaconess Medical Center Methods and compositions for treating celiac disease
JP5261601B2 (ja) 2011-09-16 2013-08-14 花王株式会社 固形状組成物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0618229A1 (en) * 1993-03-29 1994-10-05 Nisshin Flour Milling Co., Ltd. Amylase inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3116102B2 (ja) * 1991-10-30 2000-12-11 味の素株式会社 Ｌ−３，４−ジヒドロキシフェニルアラニンの製造方法
JP3195937B2 (ja) * 1992-04-22 2001-08-06 日清製粉株式会社 アミラーゼ阻害物質の取得方法
JP3504719B2 (ja) 1993-03-29 2004-03-08 日清ファルマ株式会社 アミラーゼ阻害活性を有する物質
JP3499260B2 (ja) 1993-08-06 2004-02-23 日清ファルマ株式会社 アミラーゼ阻害物質の製造方法
JP3480965B2 (ja) 1993-08-06 2003-12-22 日清ファルマ株式会社 アミラーゼ阻害物質の調製方法
JPH09194392A (ja) * 1996-01-18 1997-07-29 Nisshin Flour Milling Co Ltd アミラーゼ阻害物質

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0618229A1 (en) * 1993-03-29 1994-10-05 Nisshin Flour Milling Co., Ltd. Amylase inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, VOL. 124, 1996, ABSTRACT 278705U *

Also Published As

Publication number Publication date
EP0784978A3 (en) 1998-09-16
EP0784978B1 (en) 2003-04-02
CA2195053C (en) 2007-03-13
US5789380A (en) 1998-08-04
AU1011797A (en) 1997-07-24
JP3999825B2 (ja) 2007-10-31
JPH09194390A (ja) 1997-07-29
EP0784978A2 (en) 1997-07-23
DE69720303D1 (de) 2003-05-08
CA2195053A1 (en) 1997-07-19
DE69720303T2 (de) 2004-02-12

Similar Documents

Publication Publication Date Title
CA2567582C (en) Anti-hypertensive dietary supplement derived from salmo or oncorhynchus protein hydrolysates
AU666531B2 (en) Processes for the preparation of amylase inhibitor
EP3142681B1 (en) Peptides and compositions thereof for improvement of glycaemic management in a mammal
JP3068656B2 (ja) 新規なペプチド及びアンジオテンシン変換酵素阻害ペプチド並びにそれらを含有する経口摂食組成物
JPH06293796A (ja) 脂肪細胞分化抑制ペプチド及び当該ペプチドを有効成分とする脂肪細胞分化抑制剤
AU714225B2 (en) Agents for inhibiting accumulation of visceral fat
NO325836B1 (no) Peptid som inhiberer forhoyede triglyseridnivaer i blod, samt anvendelse derav
EP0090406A1 (en) Health food and drink
US5726291A (en) Amylase inhibitors
US5444046A (en) Amylase inhibitors
JP2006219420A (ja) 抗高血圧剤
JP3272621B2 (ja) 海苔から得られるペプチド混合物
JP3504719B2 (ja) アミラーゼ阻害活性を有する物質
JP2873327B2 (ja) アンジオテンシン変換酵素阻害剤
JP2008208096A (ja) クラゲタンパク質由来の新規ペプチドとその用途
KR20130112969A (ko) 안지오텐신 전환효소 저해용 약학 조성물 및 건강기능식품
JP3090950B2 (ja) 循環器系疾患予防剤
JP2978581B2 (ja) コレステロール抑制剤
JP2006265241A (ja) クラゲタンパク質由来の新規ペプチドとその用途
JP3220420B2 (ja) ペンタペプチド、その製造方法およびその用途
JP2794094B2 (ja) 新規ペプチド及び血圧降下剤
JPH07119234B2 (ja) トリペプチド
JPH0881390A (ja) 赤粕から調製された脂質代謝改善剤及びアンジオテンシン変換酵素阻害剤
JPH0778077B2 (ja) 新規ペプチド
JPH03118329A (ja) 血圧降下剤

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: NISSHIN PHARMA INC., NAGATA SANGYO CO., LTD

Free format text: FORMER OWNER WAS: NISSHIN FLOUR MILLING CO LTD, NAGATA SANGYO CO., LTD